|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2020―Aug―27 |
Pre-HCT lung computed tomography as an alternative to PFT during the COVID-19 Pandemic |
Masaharu Tamaki, Hideki Nakasone, Tadao Aikawa, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, et al. (+13) Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shinpei Matsumi, Ayumi Gomyo, Aki Tanihara, Machiko Kusuda, Yu Akahoshi, Shun-ichi Kimura, Shinichi Kako, Noriko Oyama-Manabe, Yoshinobu Kanda |
2 |
[GO] |
2020―Aug―18 |
Cryopreservation for all is no option in unrelated stem cell transplantation (Comment to: Dholaria B, et al. Securing the graft during pandemic: are we ready for cryopreservation for all? Biol Blood Marrow Transplant. 2020;26(7):e145-e146.) |
Alexander H. Schmidt, Deborah Buk, Alexander Platz, Marcel R.M. van den Brink |
3 |
[GO] |
2020―Jul―28 |
Guidelines For Covid-19 Management In Hematopoietic Cell Transplant And Cellular Therapy Patients |
Alpana Waghmare, Maheen Z. Abidi, Michael Boeckh, Roy F. Chemaly, Sanjeet Dadwal, Zeinab El Boghdadly, et al. (+4) Mini Kamboj, Genovefa A. Papanicolaou, Steven A. Pergam, Zainab Shahid |
4 |
[GO] |
2020―Jul―24 |
Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee |
Ghada Algwaiz, Mahmoud Aljurf, Mickey Koh, Mary M. Horowitz, Per Ljungman, Daniel Weisdorf, et al. (+31) Wael Saber, Yoshihisa Kodera, Jeff Szer, Dunia Jawdat, William A. Wood, Ruta Brazauskas, Leslie Lehmann, Marcelo C. Pasquini, Adriana Seber, Pei Hua Lu, Yoshiko Atsuta, Marcie Riches, Miguel-Angel Perales, Nina Worel, Shinichiro Okamoto, Alok Srivastava, Roy F. Chemaly, Catherine Cordonnier, Christopher E. Dandoy, John R. Wingard, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani, Navneet S. Majhail, Alpana A. Waghmare, Nelson Chao, Nicolaus Kröger, Bronwen Shaw, Mohamad Mohty, Dietger Niederwieser, Hildegard Greinix, Shahrukh K. Hashmi |
5 |
[GO] |
2020―Jun―23 |
Letter to the Editor Regarding “Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation” |
Saurabh Chhabra, Sameem Abedin, Mary Beth Graham, Tirsa M. Ferrer Marrero, Parameswaran N. Hari, Bronwen E. Shaw |
6 |
[GO] |
2020―Jun―16 |
The SARS-Cov-2 pandemic: a good time for stem cell transplantation? |
Frédéric Dutheil, Julien S Baker, Valentin Navel |
7 |
[GO] |
2020―Apr―24 |
Addressing the Impact of the Coronavirus Disease (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices |
M.I. Ardura, D.M. Hartley, C. Dandoy, L. Lehmann, S. Jaglowski, Jeffery J. Auletta |
8 |
[GO] |
2020―Apr―17 |
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States |
Zahra Mahmoudjafari, Maurice Alexander, Julianna Roddy, Ryan Shaw, Terri Lynn Shigle, Colleen Timlin, Katie Culos |
9 |
[GO] |
2020―Apr―17 |
Securing the graft during pandemic: are we ready for cryopreservation for all? |
Bhagirathbhai Dholaria, Monzr M. Al Malki, Andrew Artz, Bipin N. Savani |
10 |
[GO] |
2020―Apr―14 |
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic |
Veronika Bachanova, Michael R. Bishop, Parastoo Dahi, Bhagirathbhai Dholaria, Stephan A. Grupp, Brandon Hayes-Lattin, et al. (+8) Murali Janakiram, Richard T. Maziarz, Joseph P. McGuirk, Loretta J. Nastoupil, Olalekan O. Oluwole, Miguel-Angel Perales, David L. Porter, Peter A. Riedell |
|